NCT03378453View on ClinicalTrials.gov

Narcolepsy Protect Against Alzheimer's Disease?

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

April 7, 2016

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
NarcolepsyAmyloid Pathology
Interventions
DEVICE

PET-scan18F-AV-45

The PET-scan18F-AV-45 is a PET-scan dedicated to analyze the amyloid load in the brain with the AV45 tracer by the measurement of the mean cortical SuVr

DEVICE

PET-scan18F-AV-45

PET-scan18F-AV-45 already done in another protocol MEMENTO-AMYging

Trial Locations (1)

34295

Montpellier University Hospital, Gui de Chauliac, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT03378453 - Narcolepsy Protect Against Alzheimer's Disease? | Biotech Hunter | Biotech Hunter